EZETIMIBE; SIMVASTATIN | A209222 | ALKEM LABORATORIES LTD
Highest NADAC/Unit
$0.4524
per ea
Lowest NADAC/Unit
$0.3013
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 67877051090EZETIMIBE-SIMVASTATIN 10-80 MG | $0.4524 | EA | Generic | — | 2026-06-17 |
| 67877051030EZETIMIBE-SIMVASTATIN 10-80 MG | $0.4524 | EA | Generic | — | 2026-06-17 |
| 67877050730EZETIMIBE-SIMVASTATIN 10-10 MG | $0.3810 | EA | Generic | — | 2026-06-17 |
| 67877050790EZETIMIBE-SIMVASTATIN 10-10 MG | $0.3810 | EA | Generic | — | 2026-06-17 |
| 67877050930EZETIMIBE-SIMVASTATIN 10-40 MG | $0.3719 | EA | Generic | — | 2026-06-17 |
| 67877050990EZETIMIBE-SIMVASTATIN 10-40 MG | $0.3719 | EA | Generic | — | 2026-06-17 |
| 67877050890EZETIMIBE-SIMVASTATIN 10-20 MG | $0.3013 | EA | Generic | — | 2026-06-17 |
| 67877050830EZETIMIBE-SIMVASTATIN 10-20 MG | $0.3013 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.